Edition:
United States

Hansa Medical AB (HMED.ST)

HMED.ST on Stockholm Stock Exchange

244.00SEK
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
244.00kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
160,291
52-wk High
271.50kr
52-wk Low
95.00kr

Select another date:

Wed, Nov 29 2017

BRIEF-‍Hansa Medical's board has resolved on a directed share issue of SEK 545 mln​

* ‍HANSA MEDICAL'S BOARD OF DIRECTORS HAS RESOLVED ON A DIRECTED SHARE ISSUE OF SEK 545 MILLION​ Source text for Eikon: Further company coverage:

BRIEF-‍Hansa Medical Contemplates Directed Share Issue To Raise About Sek 545 mln​

* ‍HANSA MEDICAL CONTEMPLATES A DIRECTED SHARE ISSUE TO RAISE APPROXIMATELY SEK 545 MILLION​

BRIEF-Hansa Medical Q3 operating loss up at SEK ‍​37.4 mln

* Q3 OPERATING LOSS SEK ‍​37.4 MILLION VERSUS LOSS SEK 27.0 MILLION YEAR AGO

BRIEF-Hansa Medical: sudden death of CEO Göran Arvidson​

* ‍BIRGIT STATTIN NORINDER WILL TAKE OVER ROLE AS CHAIRMAN OF BOARD UNTIL FURTHER NOTICE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Hansa Medical shares gain on good kidney transplant drug news

LONDON Shares in Sweden's Hansa Medical jumped 12 percent on Thursday after research showed its experimental drug allowed doctors to perform successful kidney transplants in 24 out of 25 patients with a particularly high risk of organ rejection.

UPDATE 1-Hansa Medical shares gain on good kidney transplant drug news

LONDON, Aug 3 Shares in Sweden's Hansa Medical jumped 12 percent on Thursday after research showed its experimental drug allowed doctors to perform successful kidney transplants in 24 out of 25 patients with a particularly high risk of organ rejection.

BRIEF-Hansa Medical Q2 operating loss at SEK 44.9 million

* Q2 NET REVENUE SEK 0.7 MILLION VERSUS SEK 0.5 MILLION YEAR AGO

Select another date: